Lien Centre for Palliative Care, Duke-NUS Medical School, Singapore
Abstract
Background In order to increase breast and cervical cancer screening uptake in Singapore, women's perceived barriers to screening need to be identi ed and overcome. Using data from both focus groups and surveys, we aimed to assess perceived barriers and motivations for breast and cervical cancer screening. Materials and Methods We conducted 8 focus groups with 64 women, using thematic analysis to identify overarching themes related to women's attitudes towards screening. Based on recurring themes from focus groups, several hypotheses regarding potential barriers and motivations to screen were generated and tested through a national survey of 801 women aged 25-64. Results Focus group participants had misconceptions related to screening, believing that the procedures were painful. Cost was an issue, as well as ef cacy and fatalism. Conclusions By identifying barriers to and motivators for screening through a mixed-method design that has both nuance and external validity, this study offers valuable suggestions to policymakers to improve breast and cervical cancer screening uptake in Singapore.
Malhotra, C., Bilger, M., Liu, J., & Finkelstein, E. (2016). Barriers to Breast and Cervical Cancer Screening in Singapore a Mixed Methods Analysis. Asian Pacific Journal of Cancer Prevention, 17(8), 3887-3895.
MLA
Chetna Malhotra; Marcel Bilger; Joy Liu; Eric Finkelstein. "Barriers to Breast and Cervical Cancer Screening in Singapore a Mixed Methods Analysis". Asian Pacific Journal of Cancer Prevention, 17, 8, 2016, 3887-3895.
HARVARD
Malhotra, C., Bilger, M., Liu, J., Finkelstein, E. (2016). 'Barriers to Breast and Cervical Cancer Screening in Singapore a Mixed Methods Analysis', Asian Pacific Journal of Cancer Prevention, 17(8), pp. 3887-3895.
VANCOUVER
Malhotra, C., Bilger, M., Liu, J., Finkelstein, E. Barriers to Breast and Cervical Cancer Screening in Singapore a Mixed Methods Analysis. Asian Pacific Journal of Cancer Prevention, 2016; 17(8): 3887-3895.
)